Finance

Beta
Lists
CN2:FRA
Catalyst Pharmaceuticals Inc
€26.50
-0.38%
(-0.10) 1D
Jun 5, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CN2...
Open
€26.50
High
€26.50
Low
€26.50
Mkt. cap
3.83B
Avg. vol.
59.00
Volume
500.00
52-wk high
€26.70
52-wk low
€16.15
No. of employees
182
Open
€26.50
High
€26.50
Low
€26.50
Mkt. cap
3.83B
Avg. vol.
59.00
Volume
500.00
52-wk high
€26.70
52-wk low
€16.15
No. of employees
182
News stories
From sources across the web
About Catalyst Pharmaceuticals Inc
CEO-
Employees182
Founded2002
HeadquartersCoral Gables, Florida, United States
SectorBiotechnology
Websitecatalystpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
146.56M
148.39M
152.61M
149.39M
Cost of goods sold
24.97M
25.31M
27.88M
17.14M
Cost of revenue
24.97M
25.31M
27.88M
17.14M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.95M
47.47M
53.42M
49.32M
Operating expense
55.29M
56.81M
62.89M
59.02M
Total operating expenses
80.26M
82.12M
90.77M
76.16M
Operating income
66.30M
66.27M
61.85M
73.23M
Other non operating income
-
-
-
-
EBT including unusual items
69.29M
71.04M
71.90M
84.23M
EBT excluding unusual items
72.24M
73.12M
68.53M
79.48M
Income tax expense
17.18M
18.25M
19.20M
20.50M
Effective tax rate
24.80%
25.69%
26.71%
24.33%
Other operating expenses
-
-
-
-
Net income
52.11M
52.78M
52.70M
63.73M
Net profit margin
35.55%
35.57%
34.53%
42.66%
Earnings per share
0.68
0.68
0.68
0.79
Interest and investment income
5.95M
6.86M
6.69M
6.25M
Interest expense
-
-
-
-
Net interest expenses
5.95M
6.86M
6.69M
6.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
75.76M
75.68M
71.38M
83.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer